Moderna
MRNA
#1355
Rank
S$17.76 B
Marketcap
$46.17
Share price
0.89%
Change (1 day)
-65.46%
Change (1 year)
Moderna, Inc. is an American biotechnology company focused on the discovery and development of messenger RNA-based drugs.

Moderna (MRNA) Fails to deliver data

Key failure to deliver metrics for Moderna :

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for Moderna (MRNA) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for Moderna (MRNA) - since 2018

Volume in USD (price x number of shares), data since 2018

Moderna (MRNA) Failure to deliver volume, Year over Year

Year Volume (Price x Shares) Change
2024S$0.15 B15.08%
2023S$0.13 B-50.15%
2022S$0.27 B-85.7%
2021S$1.90 B158.2%
2020S$0.73 B369.18%
2019S$0.15 B1011.49%
2018S$14.15 M

FTD volume in the last 3 months for similar companies or competitors

Company FTD volume (3 months) FTD volume (1 year) Country
S$0.85 MS$6.61 M๐Ÿ‡บ๐Ÿ‡ธ USA
S$76.67 MS$0.12 B๐Ÿ‡บ๐Ÿ‡ธ USA
S$0.09 MS$0.71 M๐Ÿ‡บ๐Ÿ‡ธ USA
S$14.25 MS$43.18 M๐Ÿ‡บ๐Ÿ‡ธ USA
S$80.83 MS$0.14 B๐Ÿ‡จ๐Ÿ‡ญ Switzerland
S$0.55 MS$9.79 M๐Ÿ‡บ๐Ÿ‡ธ USA
S$22.46 MS$0.33 B๐Ÿ‡บ๐Ÿ‡ธ USA